about
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development...
Read More
27.46
0.13
(0.48%)
97,342
XNAS Volume
XNAS 28 Nov, 2025 10:05 AM (EST)
Board Meeting
The next board meeting for Zymeworks BC Inc is on 03 Dec 2025 for the purpose of Citi 2025 Global Healthcare Conference
See details
Low Financial Strength
Expensive Valuation
Technically Bullish
Momentum Trap
These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked.
View Similar
Embed DVM
Zymeworks BC Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..